Trial · NCT01472549
The Skin Prep Study
NCT01472549, Not applicable, Completed, Washington University School of Medicine; results first posted 2018-08-08
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Skin Prep Study. Trials, record NCT01472549. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01472549
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Skin Prep Study
- NCT number
- NCT01472549
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,147 participants, actual
- Lead sponsor
- Washington University School of Medicine
- Conditions
- Surgical Site Infections
- Interventions
- Iodine-alcohol, Chlorhexidine-alcohol
- First posted
- 2011-11-16
- Last updated
- 2018-08-08
- Results first posted
- 2018-08-08
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Surgical Site Infection | 30 days | Superficial or deep surgical-site infection within 30 days after cesarean delivery, on the basis of the National Healthcare Safety Network definitions of the Centers for Disease Control and Prevention. |
| Secondary | Length of Hospital Stay | 30 days | |
| Secondary | Number of Participants With Re-admissions or Office Visits for Wound-related Problems | 30 days | |
| Secondary | Number of Participants With Endometritis | 30 days | |
| Secondary | Number of Participants With Skin Irritation | 30 days | |
| Secondary | Number of Participants With Allergic Reaction | 30 days | |
| Secondary | Number of Participants With Skin Contamination After Skin Prep | 1 day | |
| Secondary | Cost Savings | 30 days |
Source ClinicalTrials.gov
Outcomes8
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Surgical Site Infection | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Length of Hospital Stay | 30 days | days | MEDIAN | |
| SECONDARY | Number of Participants With Re-admissions or Office Visits for Wound-related Problems | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Endometritis | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Skin Irritation | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Allergic Reaction | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants With Skin Contamination After Skin Prep | 1 day | The skin samples collected could not be processed for financial reasons. | ||
| SECONDARY | Cost Savings | 30 days | Cost data was not collected because it as not logistically feasible. |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Surgical Site Infection | Chlorhexidine-alcohol | 23 | Participants | ||
| Number of Participants With Surgical Site Infection | Iodine-alcohol | 42 | Participants | ||
| Length of Hospital Stay | Chlorhexidine-alcohol | 4 | Inter-Quartile Range 3 to 4 | days | |
| Length of Hospital Stay | Iodine-alcohol | 4 | Inter-Quartile Range 3 to 4 | days | |
| Number of Participants With Re-admissions or Office Visits for Wound-related Problems | Chlorhexidine-alcohol | 19 | Participants | ||
| Number of Participants With Re-admissions or Office Visits for Wound-related Problems | Iodine-alcohol | 25 | Participants | ||
| Number of Participants With Endometritis | Chlorhexidine-alcohol | 8 | Participants | ||
| Number of Participants With Endometritis | Iodine-alcohol | 11 | Participants | ||
| Number of Participants With Skin Irritation | Chlorhexidine-alcohol | 0 | Participants | ||
| Number of Participants With Skin Irritation | Iodine-alcohol | 3 | Participants |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Chlorhexidine-alcohol | 572 | |
| Overall Study | STARTED | Iodine-alcohol | 575 | |
| Overall Study | COMPLETED | Chlorhexidine-alcohol | 572 | |
| Overall Study | COMPLETED | Iodine-alcohol | 575 | |
| Overall Study | NOT COMPLETED | Chlorhexidine-alcohol | 0 | |
| Overall Study | NOT COMPLETED | Iodine-alcohol | 0 |
Source ClinicalTrials.gov
Adverse events2
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Adverse skin reactions | Skin and subcutaneous tissue disorders | Chlorhexidine-alcohol | 15 | 572 | 15 |
| other | Adverse skin reactions | Skin and subcutaneous tissue disorders | Iodine-alcohol | 15 | 575 | 15 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Chlorhexidine-alcohol | 0 | 572 |
| Total, all-cause mortality | Iodine-alcohol | 0 | 575 |
| Total, other adverse events | Chlorhexidine-alcohol | 15 | 572 |
| Total, other adverse events | Iodine-alcohol | 15 | 575 |
| Total, serious adverse events | Chlorhexidine-alcohol | 0 | 572 |
| Total, serious adverse events | Iodine-alcohol | 0 | 575 |
Source ClinicalTrials.gov
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons7
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Chlorhexidine-alcohol vs Iodine-alcohol: Number of Participants With Skin Irritation | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: Number of Participants With Allergic Reaction | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: Number of Participants With Surgical Site Infection | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: deaths from any cause | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: Number of Participants With Re-admissions or Office Visits for Wound-related Problems | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: Number of Participants With Endometritis | Trial comparisons |
| Chlorhexidine-alcohol vs Iodine-alcohol: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01472549
GET https://conductscience.org/api/trials/v1/NCT01472549/registered